Vision
Pharmaseed Bioservices’ vision is that the provision of expertly guided R&D, along with state-of-the-art laboratories, tested models and deep experience, is what is needed to address the critical components involved in analyzing medical device, biologics or drug properties. A drug or medical device that has been well-characterized and tested through the Pharmaseed program will stand a better chance of successfully completing its pre-clinical program and attracting further investment and licensing deals.

Partnerships and Collaboration
Pharmaseed is involved in several partnerships and collaborations with both industry and academia. Its publicly announced partnerships include joint programs with:

	Lannet (generics)
	PharmaB2 (added-value generics)
	AlphaRx (NCE)
	Mindgenix (third party testing using the PS1/APP mice model)

Pharmaseed is conducting talks with several other potential partners, focusing on technological in-licensing, the licensing of an innovative behavioral phenotyping platform and subcontracting a personalized-medicine application.